The first case of Teclistamab interference with serum electrophoresis and immunofixation

Article The first case of Teclistamab interference with serum electrophoresis and immunofixation was published on April 17, 2025 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 0, issue 0).

Authors

Institutions

Publication Details

Journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2025-04-17
DOI
https://doi.org/10.1515/cclm-2025-0446
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The first case of Teclistamab interference with serum electrophoresis and immunofixation

Samer Albahra, Kamran Kadkhoda, Nicole Boyert, Jason Valent et al.
Clinical Chemistry and Laboratory Medicine (CCLM)
Hepatitis B Virus Studies
article

The first case of Teclistamab interference with serum electrophoresis and immunofixation

Samer Albahra, Kamran Kadkhoda, Nicole Boyert, Jason Valent, Beth Faiman
article en

Abstract

Article The first case of Teclistamab interference with serum electrophoresis and immunofixation was published on April 17, 2025 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 0, issue 0).

Clinical Chemistry and Laboratory Medicine (CCLM)Vol. 63(7)
Cleveland Clinic (US), Cleveland Clinic Lerner College of Medicine (US), Case Western Reserve University (US)
Zero hunger
Openalex Percentile: Top 88%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.